+ Translate

Malaria - advances in vaccines

, : Malaria - advances in vaccines. Current Opinion in Infectious Diseases 8(5): 322-327

Clinical trials with candidate malaria vaccines have given moderate to poor protection levels. Recent studies designed to improve immunity are reviewed, with reference to pre-erythrocytic stage vaccines (sporozoites and intrahepatic schizogony), asexual stage vaccines (SPf66), anti-disease immunity and parasite diversity, and transmission-blocking immunity.

(PDF same-day service: $19.90)

Accession: 002889280

DOI: 10.1097/00001432-199510000-00002

Submit PDF Full Text: Here

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Related references

Anonymous, 1996: A rapid dipstick antigen capture assay for the diagnosis of falciparum malaria. WHO Informal Consultation on Recent Advances in Diagnostic Techniques and Vaccines for Malaria. Recent advances in the diagnosis of Plasmodium falciparum infections have made it possible to consider supplementing light microscopy with a standardized dipstick antigen capture assay based on the detection of a parasite-specific protein, which i...

Zapata Lopez, T.; Sanchez Gonzalez, M.C.; Bejarano Borrega, J.; Aparicio Garcia, S.; Garcia Serrano, M., 2005: Advances in vaccines against malaria. This article describes the latest advances in vaccine development against malaria. At the moment, there are several types of vaccines in investigation, directed at the different phases of the vital cycle of Plasmodium. These vaccines have been dev...

Anonymous, 2014: New malaria vaccines roadmap targets next generation products by 2030. Partners agree approach for developing vaccines capable of reducing malaria cases by 75%, and to enable malaria elimination. Central European Journal of Public Health 21(4): 206-206

Rojas Rivero, Lázara.; Sarracent Pérez, J.; Fonte Galindo, L., 2005: The most recent advances in developing vaccines against malaria. According to reports of the Pan American Health Organization, malaria transmission continues to occur in 21 countries of the Americas. Of the 835 million inhabitants of the Region of the Americas, 293 million live in areas with some possibility of...

Draper, S.J.; Angov, E.; Horii, T.; Miller, L.H.; Srinivasan, P.; Theisen, M.; Biswas, S., 2016: Recent advances in recombinant protein-based malaria vaccines. Plasmodium parasites are the causative agent of human malaria, and the development of a highly effective vaccine against infection, disease and transmission remains a key priority. It is widely established that multiple stages of the parasite&apos...

Halloran, M.E.; Struchiner, C.J.; Spielman, A., 1989: Modeling malaria vaccines. II: Population effects of stage-specific malaria vaccines dependent on natural boosting. Population effects of malaria vaccination programs will depend on the stage specificity of the vaccine, its duration of effectiveness, whether it is responsive to natural boosting, the proportion vaccinated, and the preexisting endemic conditions....

Levine, M.M.; Herrington, D.; Clyde, D.; Murphy, J.; Davis, J.; Nussenzweig, R.; Nardin, E.; Felix, A.; Heimer, E.; Gillesen, D., 1988: Malaria vaccines: experience with sporozoite vaccines against falciparum malaria. Recent advances in the development of a sporozoite vaccine for malaria are summarized.

Duffy, P.E.; Krzych, U.; Francis, S.; Fried, M., 2005: Malaria vaccines: using models of immunity and functional genomics tools to accelerate the development of vaccines against Plasmodium falciparum. Naturally acquired immunity and immunity acquired after immunization with attenuated parasites indicate that a vaccine against malaria is feasible. Several obstacles have stymied malaria vaccine development, among them our poor understanding of pr...

Hilleman, M.R., 1966: Advances in control of viral infections by nonspecific measures and by vaccines, with special reference to live mumps and rubella virus vaccines. Vaccines have been most rewarding in their contribution to the safe and effective control of many acute infectious diseases. Additional new vaccines, such as for mumps and rubella, which are reported here for the 1st time, and for multiple combine...

Plowe, C.V.; Alonso, P.; Hoffman, S.L., 2009: The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria. Journal of Infectious Diseases 200(11): 1646-1649